Table of contents

Volume 98, Issue 1
Published online 8 January 2008 (1-244)

Top

Editorials

Androgen resistance in prostate cancer FREE

J Waxman and S Ngan

Br J Cancer 98: 1; doi:10.1038/sj.bjc.6604076

Soy intake and breast cancer: elucidation of an unanswered question FREE

M D Gammon, B N Fink, S E Steck and M S Wolff

Br J Cancer 98: 2-3; doi:10.1038/sj.bjc.6604182

Top

Reviews

Updates on p53: modulation of p53 degradation as a therapeutic approach FREE

A Dey, C S Verma and D P Lane

Br J Cancer 98: 4-8; doi:10.1038/sj.bjc.6604098

Top

Minireviews

Epidemiology of soy exposures and breast cancer risk FREE

A H Wu, M C Yu, C-C Tseng and M C Pike

Br J Cancer 98: 9-14; doi:10.1038/sj.bjc.6604145

HPV and cervical cancer: screening or vaccination? FREE

F X Bosch, X Castellsagué and S de Sanjosé

Br J Cancer 98: 15-21; doi:10.1038/sj.bjc.6604146

Top

Clinical Studies

A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer FREE

J Shamash, A Davies, W Ansell, S Mcfaul, P Wilson, T Oliver and T Powles

Br J Cancer 98: 22-24; doi:10.1038/sj.bjc.6604051

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer FREE

J Bernhard, D Zahrieh, J J Zhang, G Martinelli, R Basser, C Hürny, J F Forbes, S Aebi, W Yeo, B Thürlimann, M D Green, M Colleoni, R D Gelber, M Castiglione-Gertsch, K N Price, A Goldhirsch and A S Coates for the International Breast Cancer Study Group (IBCSG)

Br J Cancer 98: 25-33; advance online publication, November 27, 2007; doi:10.1038/sj.bjc.6604092

How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients FREE

L Johnson, P Barrett-Lee, P Ellis and J M Bliss on behalf of TACT Trial Management Group

Br J Cancer 98: 34-38; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604119

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study FREE

H Thorpe, S R Brown, J R Sainsbury, T J Perren, V Hiley, M Dowsett, A Nejim and J M Brown

Br J Cancer 98: 39-44; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604120

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan FREE

J V Lacey Jr, O B Ioffe, B M Ronnett, B B Rush, D A Richesson, N Chatterjee, B Langholz, A G Glass and M E Sherman

Br J Cancer 98: 45-53; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604102

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial FREE

C-W Wu, J-M Chiou, F-S Ko, S-S Lo, J-H Chen, W-Y Lui and J Whang-Peng

Br J Cancer 98: 54-59; doi:10.1038/sj.bjc.6604097

Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review FREE

E Mitchell, S Macdonald, N C Campbell, D Weller and U Macleod

Br J Cancer 98: 60-70; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604096

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation FREE

S Cascinu, R Berardi, S Salvagni, G D Beretta, V Catalano, F Pucci, A Sobrero, P Tagliaferri, R Labianca, M Scartozzi, F Crocicchio , E Mari and A Ardizzoni

Br J Cancer 98: 71-76; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604121

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival FREE

B Nisman, H Biran, N Heching, V Barak, N Ramu, I Nemirovsky and T Peretz

Br J Cancer 98: 77-79; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604157

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours FREE

F A L M Eskens, C H Mom, A S T Planting, J A Gietema, A Amelsberg, H Huisman, L van Doorn, H Burger, P Stopfer, J Verweij and E G E de Vries

Br J Cancer 98: 80-85; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604108

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy FREE

K S Han, J Y Joung, T S Kim, I G Jeong, H K Seo, J Chung and K H Lee

Br J Cancer 98: 86-90; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604113

Top

Translational Therapeutics

Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies FREE

R Sharma, M Kacevska, R London, S J Clarke, C Liddle and G Robertson

Br J Cancer 98: 91-97; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604101

Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice FREE

F Dahm, A Bielawska, A Nocito, P Georgiev, Z M Szulc, J Bielawski, W Jochum, D Dindo, Y A Hannun and P-A Clavien

Br J Cancer 98: 98-105; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604099

Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model FREE

A Thies, P Dautel, A Meyer, U Pfüller and U Schumacher

Br J Cancer 98: 106-112; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604106

A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle FREE

K R Swanson, R C Rostomily and E C Alvord Jr

Br J Cancer 98: 113-119; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604125

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation FREE

D Balin-Gauthier, J-P Delord, M-J Pillaire, P Rochaix, J-S Hoffman, R Bugat, C Cazaux, P Canal and B C Allal

Br J Cancer 98: 120-128; doi:10.1038/sj.bjc.6604134

Top

Molecular Diagnostics

Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype FREE

M Barathova, M Takacova, T Holotnakova, A Gibadulinova, A Ohradanova, M Zatovicova, A Hulikova, J Kopacek, S Parkkila, C T Supuran, S Pastorekova and J Pastorek

Br J Cancer 98: 129-136; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604111

Immunohistochemical categorisation of ductal carcinoma in situ of the breast FREE

P Meijnen, J L Peterse, N Antonini, E J Th Rutgers and M J van de Vijver

Br J Cancer 98: 137-142; advance online publication, November 27, 2007; doi:10.1038/sj.bjc.6604112

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy FREE

F V Negri, N Campanini, R Camisa, F Pucci, S Bui, G Ceccon, R Martinelli, M Fumagalli, P L Losardo, P Crafa, C Bordi, S Cascinu and A Ardizzoni

Br J Cancer 98: 143-147; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604131

Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer FREE

Y Mizukami, K Kono, Y Kawaguchi, H Akaike, K Kamimura, H Sugai and H Fujii

Br J Cancer 98: 148-153; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604149

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers FREE

S Savic, C Tapia, B Grilli, A Rufle, M P Bihl, A de Vito Barascud, M Herzog, L Terracciano, F Baty and L Bubendorf

Br J Cancer 98: 154-160; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604142

Top

Epidemiology

Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case–control study FREE

L A Anderson, G Gridley, E A Engels, L M Morton, J R Cerhan, W Cozen, R K Severson, S Davis, P Hartge and M S Linet

Br J Cancer 98: 161-164; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604127

Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989–2003 FREE

H P van de Nieuwenhof, L F A G Massuger, J A de Hullu, M A P C van Ham, J A A M van Dijck, A G Siebers and R L M Bekkers

Br J Cancer 98: 165-167; doi:10.1038/sj.bjc.6604118

Possible protective effect of green tea intake on risk of adult leukaemia FREE

M Zhang, X Zhao, X Zhang and C D'Arcy J Holman

Br J Cancer 98: 168-170; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604140

Testicular cancer in twins: a meta-analysis FREE

R E Neale, P Carrière, M F G Murphy and P D Baade

Br J Cancer 98: 171-173; advance online publication, December 11, 2007; doi:10.1038/sj.bjc.6604136

Risk of testicular germ-cell tumours in relation to childhood physical activity FREE

M B Cook, Y Zhang, B I Graubard, M V Rubertone, R L Erickson and K A McGlynn

Br J Cancer 98: 174-178; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604109

Birth weight and melanoma risk: a population-based case–control study FREE

I Franco-Lie, T Iversen, T E Robsahm and M Abdelnoor

Br J Cancer 98: 179-182; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604159

Hodgkin's disease and birth outcome: a Danish nationwide cohort study FREE

V Langagergaard, E Horvath-Puho, M Nørgaard, B Nørgård and H T Sørensen

Br J Cancer 98: 183-188; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604126

Reproductive factors and pancreatic cancer risk: a Norwegian cohort study FREE

I Heuch, B K Jacobsen, G Albrektsen and G Kvåle

Br J Cancer 98: 189-193; advance online publication, November 13, 2007; doi:10.1038/sj.bjc.6604095

Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study FREE

G C Kabat, A B Miller, M Jain and T E Rohan

Br J Cancer 98: 194-198; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604110

Population attributable fractions for ovarian cancer in Swedish women by morphological type FREE

C Granström, J Sundquist and K Hemminki

Br J Cancer 98: 199-205; advance online publication, December 11, 2007; doi:10.1038/sj.bjc.6604135

A case–control study of the impact of the East Anglian breast screening programme on breast cancer mortality FREE

P C Allgood, J Warwick, R M L Warren, N E Day and S W Duffy

Br J Cancer 98: 206-209; advance online publication, December 4, 2007; doi:10.1038/sj.bjc.6604123

Breast cancer risk factors and a novel measure of volumetric breast density: cross-sectional study FREE

M Jeffreys, R Warren, R Highnam and G Davey Smith

Br J Cancer 98: 210-216; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604122

The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study FREE

J Gentil-Brevet, M Colonna, A Danzon, P Grosclaude, G Chaplain, M Velten, F Bonnetain and P Arveux

Br J Cancer 98: 217-224; doi:10.1038/sj.bjc.6604163

Childhood leukaemia and population movements in France, 1990–2003 FREE

S Bellec, B Baccaïni, A Goubin, J Rudant, M Ripert, D Hémon and J Clavel

Br J Cancer 98: 225-231; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604141

Use of NSAIDs, smoking and lung cancer risk FREE

J H Olsen, S Friis, A H Poulsen, J Fryzek, H Harving, A Tjønneland, H T Sørensen and W Blot

Br J Cancer 98: 232-237; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604151

Top

Letters to the Editor

Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy FREE

R A Cox and S Sundar

Br J Cancer 98: 238-239; doi:10.1038/sj.bjc.6604052

A prospective study of grapefruit and grapefruit juice intake and breast cancer risk FREE

E H Kim, S E Hankinson, A H Eliassen and W C Willett

Br J Cancer 98: 240-241; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604105

On the possible role of PIF in myofibrillar proteins mobilisation from skeletal muscles in the presence of non-malignant foci of growth in organism FREE

E A Rapoport

Br J Cancer 98: 242; advance online publication, November 20, 2007; doi:10.1038/sj.bjc.6604116

Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy FREE

D A C Deans, S J Wigmore, H Gilmour, M J Tisdale, K C H Fearon and J A Ross

Br J Cancer 98: 243; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604117

Top

Book Review

Evidence-Based Paediatric Oncology: Second Edition FREE

J Anderson

Br J Cancer 98: 244; doi:10.1038/sj.bjc.6604147

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT

naturejobs